I. Ho

发表

Angiopoietin: A TIE(d) Balance in Tumor Angiogenesis

W. Shim, P. Wong, I. Ho, 2007, Molecular Cancer Research.

Pathogenic mutations in neurofibromin identifies a leucine-rich domain regulating glioma cell invasiveness

B. Ang, D. Virshup, Phoebe Um, 2019, Oncogene.

An Efficient and Safe Herpes Simplex Virus Type 1 Amplicon Vector for Transcriptionally Targeted Therapy of Human Hepatocellular Carcinomas.

H. Huynh, K. S. Lim, P. Lam, 2007, Molecular therapy : the journal of the American Society of Gene Therapy.

FasL and FADD delivery by a glioma-specific and cell cycle-dependent HSV-1 amplicon virus enhanced apoptosis in primary human brain tumors

P. Lam, W. Ng, I. Ho, 2010, Molecular Cancer.

HSV-1 amplicon viral vector-mediated gene transfer to human bone marrow-derived mesenchymal stem cells

P. Lam, P. Cheang, K. Hui, 2008, Cancer Gene Therapy.

Matrix metalloproteinase‐1‐mediated mesenchymal stem cell tumor tropism is dependent on crosstalk with stromal derived growth factor 1/C‐X‐C chemokine receptor 4 axis

P. Lam, K. Hui, I. Ho, 2014, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

Tumor Tropism of Mesenchymal Stem Cells

P. Lam, I. Ho, 2013 .

Redox-Active Mn Porphyrin-based Potent SOD Mimic, MnTnBuOE-2-PyP5+, Enhances Carbenoxolone-Mediated TRAIL-Induced Apoptosis in Glioblastoma Multiforme

I. Batinic-Haberle, P. Lam, K. Hui, 2016, Stem Cell Reviews and Reports.

Targeting human glioma cells using HSV-1 amplicon peptide display vector

P. Lam, K. Hui, G. Wang, 2010, Gene Therapy.

Paracrine factors of human fetal MSCs inhibit liver cancer growth through reduced activation of IGF-1R/PI3K/Akt signaling.

H. Huynh, A. Chung, N. Iyer, 2015, Molecular therapy : the journal of the American Society of Gene Therapy.

An efficient and safe herpes simplex virus type 1 amplicon vector for transcriptionally targeted therapy of human hepatocellular carcinomas.

H. Huynh, K. S. Lim, P. Lam, 2007, Molecular therapy : the journal of the American Society of Gene Therapy.

Signaling molecules and pathways involved in MSC tumor tropism.

P. Lam, I. Ho, 2013, Histology and histopathology.

Hybrid herpes simplex virus/Epstein–Barr virus amplicon viral vectors confer enhanced transgene expression in primary human tumors and human bone marrow‐derived mesenchymal stem cells

H. Huynh, P. Lam, I. Ho, 2010, The journal of gene medicine.

Optimal purification method for Herpes-based viral vectors that confers minimal cytotoxicity for systemic route of vector administration.

P. Lam, K. Hui, I. Ho, 2007, Journal of virological methods.

Glioma-specific and cell cycle-regulated herpes simplex virus type 1 amplicon viral vector.

P. Lam, K. Hui, I. Ho, 2004, Human gene therapy.

Targeting proliferating tumor cells via the transcriptional control of therapeutic genes

P. Lam, K. Hui, I. Ho, 2006, Cancer Gene Therapy.

Matrix Metalloproteinase 1 Is Necessary for the Migration of Human Bone Marrow-Derived Mesenchymal Stem Cells Toward Human Glioma

P. Lam, P. Cheang, K. Hui, 2009, Stem cells.

Nanosized bioceramic particles could function as efficient gene delivery vehicles with target specificity for the spleen

P. Lam, P. Cheang, K. Hui, 2007, Gene Therapy.

Recent Advances in Glioma Therapy: Combining Vascular Normalization and Immune Checkpoint Blockade

I. Ho, R. Ho, 2021, Cancers.

Interleukin-13 receptor alpha 2 cooperates with EGFRvIII signaling to promote glioblastoma multiforme

W. Cavenee, P. Lam, T. Kordula, 2017, Nature Communications.

Contribution of the Microenvironmental Niche to Glioblastoma Heterogeneity

W. Shim, I. Ho, 2017, BioMed research international.

Combined treatment of Nimotuzumab and rapamycin is effective against temozolomide-resistant human gliomas regardless of the EGFR mutation status

P. Lam, X. Toh, D. Chong, 2015, BMC Cancer.

Identification and characterization of novel human glioma-specific peptides to potentiate tumor-specific gene delivery.

P. Lam, K. Hui, I. Ho, 2004, Human gene therapy.

Human Bone Marrow‐Derived Mesenchymal Stem Cells Suppress Human Glioma Growth Through Inhibition of Angiogenesis

P. Lam, K. Hui, H. Toh, 2013, Stem cells.

Combined treatment of Nimotuzumab and rapamycin is effective against temozolomide-resistant human gliomas regardless of the EGFR mutation status

P. Lam, X. Toh, D. Chong, 2015, BMC Cancer.

Interleukin-13 receptor alpha 2 cooperates with EGFRvIII signaling to promote glioblastoma multiforme

W. Cavenee, P. Lam, T. Kordula, 2017, Nature Communications.

Redox-Active Mn Porphyrin-based Potent SOD Mimic, MnTnBuOE-2-PyP5+, Enhances Carbenoxolone-Mediated TRAIL-Induced Apoptosis in Glioblastoma Multiforme

I. Batinic-Haberle, P. Lam, K. Hui, 2016, Stem Cell Reviews and Reports.

Carbenoxolone enhances TRAIL-induced apoptosis through the upregulation of death receptor 5 and inhibition of gap junction intercellular communication in human glioma.

P. Lam, K. Hui, W. Ng, 2013, Stem cells and development.

Isolation of peptide ligands that interact specifically with human glioma cells

P. Lam, K. Hui, I. Ho, 2010, Peptides.

Engineering an improved cell cycle-regulatable herpes simplex virus type 1 amplicon vector with enhanced transgene expression in proliferating cells yet attenuated activities in resting cells.

P. Lam, K. Hui, I. Ho, 2007, Human gene therapy.

Human Bone Marrow‐Derived Mesenchymal Stem Cells Suppress Human Glioma Growth Through Inhibition of Angiogenesis

P. Lam, K. Hui, H. Toh, 2013 .

FasL and FADD delivery by a glioma-specific and cell cycle-dependent HSV-1 amplicon virus enhanced apoptosis in primary human brain tumors

P. Lam, W. Ng, I. Ho, 2010, Molecular Cancer.